• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于新型血糖预测功能对使用一滴血糖仪的2型糖尿病成人患者血糖管理及记录影响的回顾性队列研究。

Effects of a Novel Blood Glucose Forecasting Feature on Glycemic Management and Logging in Adults With Type 2 Diabetes Using One Drop: Retrospective Cohort Study.

作者信息

Imrisek Steven D, Lee Matthew, Goldner Dan, Nagra Harpreet, Lavaysse Lindsey M, Hoy-Rosas Jamillah, Dachis Jeff, Sears Lindsay E

机构信息

One Drop, New York, NY, United States.

出版信息

JMIR Diabetes. 2022 May 3;7(2):e34624. doi: 10.2196/34624.

DOI:10.2196/34624
PMID:35503521
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9115662/
Abstract

BACKGROUND

Personalized feedback is an effective behavior change technique frequently incorporated into mobile health (mHealth) apps. Innovations in data science create opportunities for leveraging the wealth of user data accumulated by mHealth apps to generate personalized health forecasts. One Drop's digital program is one of the first to implement blood glucose forecasts for people with type 2 diabetes. The impact of these forecasts on behavior and glycemic management has not been evaluated to date.

OBJECTIVE

This study sought to evaluate the impact of exposure to blood glucose forecasts on blood glucose logging behavior, average blood glucose, and percentage of glucose points in range.

METHODS

This retrospective cohort study examined people with type 2 diabetes who first began using One Drop to record their blood glucose between 2019 and 2021. Cohorts included those who received blood glucose forecasts and those who did not receive forecasts. The cohorts were compared to evaluate the effect of exposure to blood glucose forecasts on logging activity, average glucose, and percentage of glucose readings in range, after controlling for potential confounding factors. Data were analyzed using analysis of covariance (ANCOVA) and regression analyses.

RESULTS

Data from a total of 1411 One Drop users with type 2 diabetes and elevated baseline glucose were analyzed. Participants (60.6% male, 795/1311; mean age 50.2 years, SD 11.8) had diabetes for 7.1 years on average (SD 7.9). After controlling for potential confounding factors, blood glucose forecasts were associated with more frequent blood glucose logging (P=.004), lower average blood glucose (P<.001), and a higher percentage of readings in range (P=.03) after 12 weeks. Blood glucose logging partially mediated the relationship between exposure to forecasts and average glucose.

CONCLUSIONS

Individuals who received blood glucose forecasts had significantly lower average glucose, with a greater amount of glucose measurements in a healthy range after 12 weeks compared to those who did not receive forecasts. Glucose logging was identified as a partial mediator of the relationship between forecast exposure and week-12 average glucose, highlighting a potential mechanism through which glucose forecasts exert their effect. When administered as a part of a comprehensive mHealth program, blood glucose forecasts may significantly improve glycemic management among people living with type 2 diabetes.

摘要

背景

个性化反馈是一种有效的行为改变技术,经常被纳入移动健康(mHealth)应用程序中。数据科学的创新为利用mHealth应用程序积累的大量用户数据来生成个性化健康预测创造了机会。One Drop的数字项目是最早为2型糖尿病患者实施血糖预测的项目之一。迄今为止,这些预测对行为和血糖管理的影响尚未得到评估。

目的

本研究旨在评估接触血糖预测对血糖记录行为、平均血糖以及血糖值在正常范围内的百分比的影响。

方法

这项回顾性队列研究调查了2019年至2021年间首次开始使用One Drop记录血糖的2型糖尿病患者。队列包括接受血糖预测的患者和未接受预测的患者。在控制潜在混杂因素后,比较各队列以评估接触血糖预测对记录活动、平均血糖以及血糖读数在正常范围内的百分比的影响。使用协方差分析(ANCOVA)和回归分析对数据进行分析。

结果

共分析了1411名2型糖尿病且基线血糖升高的One Drop用户的数据。参与者(60.6%为男性,795/1311;平均年龄50.2岁,标准差11.8)平均患糖尿病7.1年(标准差7.9)。在控制潜在混杂因素后,12周后血糖预测与更频繁的血糖记录相关(P = 0.004)、平均血糖更低(P < 0.001)以及血糖值在正常范围内的读数百分比更高(P = 0.03)。血糖记录部分介导了预测暴露与平均血糖之间的关系。

结论

与未接受预测的个体相比,接受血糖预测的个体平均血糖显著更低,且12周后在健康范围内的血糖测量次数更多。血糖记录被确定为预测暴露与第12周平均血糖之间关系的部分中介因素,突出了血糖预测发挥作用的潜在机制。当作为综合mHealth项目的一部分实施时,血糖预测可能会显著改善2型糖尿病患者的血糖管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/917c/9115662/4a55eaa47269/diabetes_v7i2e34624_fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/917c/9115662/c7c8f2478fe0/diabetes_v7i2e34624_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/917c/9115662/832790e50906/diabetes_v7i2e34624_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/917c/9115662/7cedac9c8eca/diabetes_v7i2e34624_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/917c/9115662/f9a2c3f6b6a8/diabetes_v7i2e34624_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/917c/9115662/c678e51c0e50/diabetes_v7i2e34624_fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/917c/9115662/4a55eaa47269/diabetes_v7i2e34624_fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/917c/9115662/c7c8f2478fe0/diabetes_v7i2e34624_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/917c/9115662/832790e50906/diabetes_v7i2e34624_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/917c/9115662/7cedac9c8eca/diabetes_v7i2e34624_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/917c/9115662/f9a2c3f6b6a8/diabetes_v7i2e34624_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/917c/9115662/c678e51c0e50/diabetes_v7i2e34624_fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/917c/9115662/4a55eaa47269/diabetes_v7i2e34624_fig6.jpg

相似文献

1
Effects of a Novel Blood Glucose Forecasting Feature on Glycemic Management and Logging in Adults With Type 2 Diabetes Using One Drop: Retrospective Cohort Study.一项关于新型血糖预测功能对使用一滴血糖仪的2型糖尿病成人患者血糖管理及记录影响的回顾性队列研究。
JMIR Diabetes. 2022 May 3;7(2):e34624. doi: 10.2196/34624.
2
Impact of a Combined Continuous Glucose Monitoring-Digital Health Solution on Glucose Metrics and Self-Management Behavior for Adults With Type 2 Diabetes: Real-World, Observational Study.连续血糖监测与数字健康解决方案相结合对2型糖尿病成人患者血糖指标及自我管理行为的影响:真实世界观察性研究
JMIR Diabetes. 2023 Sep 11;8:e47638. doi: 10.2196/47638.
3
Personalized glucose forecasting for type 2 diabetes using data assimilation.使用数据同化技术对2型糖尿病进行个性化血糖预测。
PLoS Comput Biol. 2017 Apr 27;13(4):e1005232. doi: 10.1371/journal.pcbi.1005232. eCollection 2017 Apr.
4
The Diabits App for Smartphone-Assisted Predictive Monitoring of Glycemia in Patients With Diabetes: Retrospective Observational Study.用于糖尿病患者血糖智能手机辅助预测监测的Diabits应用程序:回顾性观察研究。
JMIR Diabetes. 2020 Sep 22;5(3):e18660. doi: 10.2196/18660.
5
Role of Digital Engagement in Diabetes Care Beyond Measurement: Retrospective Cohort Study.数字参与在糖尿病护理中的作用:超越测量的回顾性队列研究。
JMIR Diabetes. 2021 Feb 18;6(1):e24030. doi: 10.2196/24030.
6
Improved Glycemic Control With a Digital Health Intervention in Adults With Type 2 Diabetes: Retrospective Study.数字健康干预改善2型糖尿病成人患者的血糖控制:回顾性研究
JMIR Diabetes. 2021 Jun 2;6(2):e28033. doi: 10.2196/28033.
7
Impact of Use Frequency of a Mobile Diabetes Management App on Blood Glucose Control: Evaluation Study.移动糖尿病管理应用程序使用频率对血糖控制的影响:评估研究。
JMIR Mhealth Uhealth. 2019 Mar 7;7(3):e11933. doi: 10.2196/11933.
8
Effectiveness of Lilly Connected Care Program (LCCP) App-Based Diabetes Education for Patients With Type 2 Diabetes Treated With Insulin: Retrospective Real-World Study.礼来连接关爱计划(LCCP)APP 式糖尿病教育对接受胰岛素治疗的 2 型糖尿病患者的疗效:回顾性真实世界研究。
JMIR Mhealth Uhealth. 2020 Mar 6;8(3):e17455. doi: 10.2196/17455.
9
A Personalized Mobile Health Program for Type 2 Diabetes During the COVID-19 Pandemic: Single-Group Pre-Post Study.2019年冠状病毒病大流行期间针对2型糖尿病的个性化移动健康计划:单组前后对照研究
JMIR Diabetes. 2021 Jul 9;6(3):e25820. doi: 10.2196/25820.
10
One Drop | Mobile: An Evaluation of Hemoglobin A1c Improvement Linked to App Engagement.一滴 | 移动应用:与应用程序参与度相关的糖化血红蛋白改善情况评估
JMIR Diabetes. 2017 Aug 24;2(2):e21. doi: 10.2196/diabetes.8039.

引用本文的文献

1
Seizure forecasting: Where do we stand?癫痫预测:我们处于什么位置?
Epilepsia. 2023 Dec;64 Suppl 3(Suppl 3):S62-S71. doi: 10.1111/epi.17546. Epub 2023 Mar 8.

本文引用的文献

1
The Effects of Continuous Usage of a Diabetes Management App on Glycemic Control in Real-world Clinical Practice: Retrospective Analysis.糖尿病管理应用程序的连续使用对真实临床实践中血糖控制的影响:回顾性分析。
J Med Internet Res. 2021 Jul 15;23(7):e23227. doi: 10.2196/23227.
2
Comparing Two Commercially Available Diabetes Apps to Explore Challenges in User Engagement: Randomized Controlled Feasibility Study.比较两款商用糖尿病应用程序以探索用户参与度方面的挑战:随机对照可行性研究。
JMIR Form Res. 2021 Jun 16;5(6):e25151. doi: 10.2196/25151.
3
Improved Glycemic Control With a Digital Health Intervention in Adults With Type 2 Diabetes: Retrospective Study.
数字健康干预改善2型糖尿病成人患者的血糖控制:回顾性研究
JMIR Diabetes. 2021 Jun 2;6(2):e28033. doi: 10.2196/28033.
4
Toward a Multivariate Prediction Model of Pharmacological Treatment for Women With Gestational Diabetes Mellitus: Algorithm Development and Validation.针对妊娠糖尿病女性药物治疗的多变量预测模型:算法的开发和验证。
J Med Internet Res. 2021 Mar 10;23(3):e21435. doi: 10.2196/21435.
5
Effectiveness of Disease-Specific mHealth Apps in Patients With Diabetes Mellitus: Scoping Review.疾病特异性移动医疗应用程序在糖尿病患者中的有效性:范围综述。
JMIR Mhealth Uhealth. 2021 Feb 15;9(2):e23477. doi: 10.2196/23477.
6
Can mHealth and eHealth improve management of diabetes and hypertension in a hard-to-reach population? -lessons learned from a process evaluation of digital health to support a peer educator model in Cambodia using the RE-AIM framework.移动健康和电子健康能否改善难以接触人群的糖尿病和高血压管理?——从数字健康过程评估中汲取的经验教训,以支持柬埔寨采用RE-AIM框架的同伴教育模式。
Mhealth. 2020 Oct 5;6:40. doi: 10.21037/mhealth-19-249. eCollection 2020.
7
9. Pharmacologic Approaches to Glycemic Treatment: .9. 血糖治疗的药物学方法: 。
Diabetes Care. 2021 Jan;44(Suppl 1):S111-S124. doi: 10.2337/dc21-S009.
8
5. Facilitating Behavior Change and Well-being to Improve Health Outcomes: .5. 促进行为改变和幸福感以改善健康结果:。
Diabetes Care. 2021 Jan;44(Suppl 1):S53-S72. doi: 10.2337/dc21-S005.
9
Toward Detecting Infection Incidence in People With Type 1 Diabetes Using Self-Recorded Data (Part 1): A Novel Framework for a Personalized Digital Infectious Disease Detection System.使用自我记录数据检测 1 型糖尿病患者的感染发生率(第 1 部分):个性化数字传染病检测系统的新框架。
J Med Internet Res. 2020 Aug 12;22(8):e18911. doi: 10.2196/18911.
10
Precision Health Analytics With Predictive Analytics and Implementation Research: JACC State-of-the-Art Review.精准医疗分析中的预测分析和实施研究:JACC 最新综述。
J Am Coll Cardiol. 2020 Jul 21;76(3):306-320. doi: 10.1016/j.jacc.2020.05.043.